Helsinn Group and Chugai Pharma Marketing Enter into Agreement for Marketing Rights of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) in The UK and Ireland and for Palonosetron Monotherapy in The UK
Jul 17, 2014
Helsinn Group and Chugai Pharma Marketing Enter into Agreement for Marketing Rights of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) in The UK and Ireland and for Palonosetron Monotherapy in The UK
Helsinn Group and Chugai Pharma Marketing Enter into Agreement for Marketing Rights of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) in The UK and Ireland and for Palonosetron Monotherapy in The UK
